跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSUVASTATINA/RAMIPRIL EGIS 20 MG/5 MG CÁPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROSUVASTATINA/RAMIPRIL EGIS 20 MG/5 MG CÁPSULAS DURAS
Approved
STANDARD
ROSUVASTATINA/RAMIPRIL EGIS 20 MG/5 MG CÁPSULAS DURAS
Egis Pharmaceuticals Plc.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 12, 2022
Approval ID
3622b01176109111
Company
Egis Pharmaceuticals Plc.
Type
Standard
Approval Details
Approval Id
3622b01176109111
Drug Cima Aemps Name
ROSUVASTATINA/RAMIPRIL EGIS 20 MG/5 MG CÁPSULAS DURAS
Register Number
86122
Holder Company Name
Egis Pharmaceuticals Plc.
Marketing Company Name
Egis Pharmaceuticals Plc.
Authorization Date
2022-04-12
Dosage Form
CÁPSULA DURA
Dose
20 mg/5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Egis Pharmaceuticals Plc.
Active Ingredients
ROSUVASTATINA CALCICA
20,84 mg
RAMIPRIL
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 12, 2022
Approval ID
3622b01176109111
Type
Standard
Back to CIMA-AEMPS Approvals
